Brinker Capital Investments, LLC Grifols Sa Transaction History

Brinker Capital Investments, LLC

  • $5.01 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
BUY
$5.95 - $14.3 $66,181 - $159,058
11,123 New
11,123 $69,000
Q3 2019

Nov 14, 2019
SELL
$19.85 - $22.76 $169,737 - $194,620
-8,551 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$17.59 - $21.1 $149,092 - $178,843
8,476 Added 11301.33%
8,551 $180,000
Q1 2019

May 14, 2019
BUY
$18.01 - $20.11 $1,350 - $1,508
75 New
75 $2,000

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email